Navigation Links
Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
Date:3/27/2013

SAN ANTONIO, March 27, 2013 /PRNewswire/ -- For years, physicians have prescribed Prednisolone (pred NIS oh lone) in a 15 mg/5 mL standard as a rescue medicine to treat severe asthma attacks, especially in children.  Unfortunately, its taste has been so unpleasant the patient often vomits after swallowing the medication and resists further usage.  Mission Pharmacal Company has recently introduced a new flavored Prednisolone Sodium Phosphate Oral Solution 25mg/5 mL in specific markets in the United States, with plans to have the medicine available nationally as early as April 2013.

(Photo: http://photos.prnewswire.com/prnh/20130327/PH84704)

This new liquid oral solution has a "yummy" grape taste and the higher strength means lower volume for pediatric patients.  Its 40 percent less volume compared to the 15mg formula translates to ease in administration to children.  And its 8 oz. bottle provides greater flexibility in prescribing.

Dr. Dennis E. Dilley , medical director of Dilley Allergy & Asthma Specialists, LLP and a board-certified allergist/immunologist, says, "Kids actually take the medicine easily.  There's no need to force it.  They don't spit it out.  And there's no need for parents to 'chase' it with a cookie or cracker.  Its palatability means the medicine can actually be given and taken in the prescribed dosage.  An easy-to-follow chart accompanies the medicine and is very helpful."

Asthma is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing.  Asthma is caused by inflammation in the airways.  When an asthma attack occurs, the muscles surrounding the airways become tight and the lining of the air passages swells.  This reduces the amount of air that can pass by.[i]  As many as seven million children in the United States have asthma.  This means that for one or two kids out of 10, breathing can sometimes be difficult.  Asthma is hereditary and can surface at any age, in an infant or an adult, but is most common in school-age kids.[ii]  Medications for asthma are classified as "rescue" or "controlling."

"We are excited to offer Prednisolone Sodium Phosphate Oral Solution 25 mg," states Clint Corwin , Senior Director Pediatric Rx Products at Mission Pharmacal Company.  "We're pleased to provide a rescue medicine for those suffering an asthma attack that has a pleasant taste so kids don't balk when needing it.  The stronger formulation aids in patient compliancy."                 

Mission Pharmacal's Pediatric Sales Team is supporting the product with an aggressive, multifaceted marketing program directed to prescribing physicians and other healthcare providers, pharmacies, and patients.  Patients prescribed Prednisolone Sodium Phosphate Oral Solution will be offered a coupon through their physician's office to be redeemed at the pharmacy when the prescription is filled.  This savings coupon will result in a copay similar to the cost of a generic that has the 15mg strength.  For more information about this product, visit prednisolone25.com.

About Mission Pharmacal Company

Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients and FDA-approved methods of manufacturing, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation®*, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit missionpharmacal.com.

[i] A.D.A.M. Medical Encyclopedia. National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA

[ii] http://kidshealth.org

*March of Dimes does not endorse specific products or brands.  March of Dimes is a registered trademark of the March of Dimes Foundation.

 


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
2. European Commission Designates MST-188 As An Orphan Medicinal Product
3. PointCross Life Sciences SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDAs Upcoming e-Data Submission Mandate
4. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
5. Codonics Safe Label System and The Emily Jerry Foundation on "Mission of Safety" during National Patient Safety Week
6. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
7. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
8. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
9. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
10. Salveo Specialty Pharmacy, Inc. Completes Additional Equity and Debt Financings and Acquisition of Mission Road Pharmacy
11. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a family ... and Raleigh regions, is organizing an extended charity drive to benefit the family ... abnormality. , After struggling since birth with several health challenges, T.J. was later ...
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):